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Using gtl tet;rrrlotion and pha~oernxslinkin@ cxprim6nls. WC hrrc idrntilictl pruhinx alt~lruut 53 kLh in wixc in b&r ret yliama (.Cd) und ~crvieul 
cutcinsrmn (H&N) cctl CX~~UCIS which bind ICI rhc ncyrCvc regulatory rcpian 4 JC virus (ICY) curly promater. fhlt gliirl cell pro&in hinds IO ilr 
eagn:ttc protm~r slcmcn~ with Icscr aillnity when campurcd IO the protein prcrcnt in kick cclk Purrhsr, llrcxr pralrina intcractcd dikrcn~iolly 
IO tin olipanuctcalidc, cunlaininy the ncighbtlring cis+icling domain. which iz reeognixed by nuzlsrr RcWr I (NFL). Thcrc findings rug~a~ Ihut 
the inrcrnctianx of thr 53 kGu HcLw pralcin mayeomribule 13 the ncprivc regul:Vion olJCY r;lrty pramarcr in H&h ccllx. 
JC: virus: Trtrnxcriplion t&tar; CM cell: ll~l.z~ cclt; 7’.unriycn promolcr 
1. 1NTRQDUCTIGN 
The human papova virus, JC (JCV), causes a fatal 
demyelinating disease, progressive multifocal Icucoen= 
ccphalopathy (PML) [I]. Although, JCV infects most 
of the human population in early childhood, antibodies 
against it have been detected in 60-8090 of adults [2], It 
remains inactive in most cases while causing PML only 
in immunocompromised individuals [3], The regulatory 
region of the prototype (Madi) strain of JCV, which 
consists of a 98 bp tandem repcat (Fig. I), has been 
demonstrated to determine the tissue specificity of the 
expression of viral early genes [4,5]. The tissue-specific 
expression of JCV T antigen has been presumed to be 
determined by an interplay of positive and negative reg- 
ulatory factors [6,7]. The early promoter has a consen- 
sus sequence for the NFl binding domain which has 
been found to affect its transcription positively in brain 
nuclear extract [6], Both, glial and HcLa cells have been 
found to have proteins which bind to the NFl domain 
[6,d]. A 45 kDa protein which binds to this region has 
been purified from calf brain extract [7]. This protein 
stimulated viral RNA synthesis in vitro when comple- 
mented with glial or HeLa cell nuclear extracts. How- 
ever, experiments involving formation of heterokaryons 
between JCV-transformed hamster glial cells, expressing 
JCV T antigen, and mouse fibroblasts uggest that cel- 
lular factor(s) present in non-glial cells may negatively 
regulate viral gene expression and thus contribute to the 
restricted tissue specificity of JCV transcription [9]. 
The binucleate heterokaryons formed in this study did 
not express T-antigen, Subsequently, some of the sub- 
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clones that lost murinc chromosomes starred expressing 
T-antigen. The negative regulation of JCV promoter in 
non-glial cells has also been shown to be regulated by 
the c-is-acting domain of JCV promoter [lo]. In these 
studies, synthetic oligonuclcotides panning the JCV 
early region, inserted into expression vectors were used 
in rransfection assays with glial and non-glial cells. Two 
of the aligonucleotidcs used in this study (A and B, 
Fig. 1) stimulated the activity of the reporter gene in 
glial cells but decreased the basal activity in non-glial 
cells. JCV early promoter has a tandem repeat of AGG- 
GA, present between TATA box and NFl consensus se- 
quence. A careful look at the two oligonuclcotides re- 
veals that both of them had an AGGGA pentanuclcotide 
repeat divided between them (see Fig. l), suggesting a
negative role of AGGGAAGGGA in the regulation of 
JCV early promoter in non-glial cells, This conclusion 
is supported by the presence of similar domains in the 
negative regulatory regions of other genes. Rat cmbry- 
onic myosine heavy chain gene and c-myc gene rcguta- 
tory regions contain AGGGAAGGAGA and AGGGA- 
AAGGGA domains respectively [l 1,121. Both of these 
regions have been shown to have silencer activity. In the 
present study we have used a synthetic oligonucteotide 
containing an intact AGGGA pentanucleotide r peat 
for gel retardation and photocrosstinking experiments 
to identify the protein factors interacting with this 
region. 
2. MATERIALS AND METHODS 
Nuclear extracts from rat glioma (C6) and human HcLa cells wcrc 
made using a previously described method [13], DNA-binding condi- 
tions were as described [14], except that the final reaction volume of 
20 ~41 contained 50 fmol probe, 3 fig (HeLa) or 6 c(g (C6) nuclear pro- 
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771~ putdve nrgarivc rcgulnrory rc&m is flanked by 
n TATA bax on one side and an NFl binding consensus 
sequence on the other side (Fig. I). Since the duplex 
containing the TATA box (Duplex A, Fig, I) has been 
3. RESULTS AND DISCUSSIBN 
found to interact with proteins of similar molecular 
weight in both glinl nnd HeLa cell extract whereas the 
- A previous tudy has shown that the region of .lCV 
early promoter, including the AGGGA repeat, could 
down-regulntc tht promoter in non-@1 cells [lo], In Q 
the present study, we used a synthetic oligonucleotide 
representing this part of the JCV regulatory region 
(Duplex C, Fig. l), to identify cellular proteins from 
both glial and non-glial cells which bind to this cis cle- 
ment. Duplex C showed a strong band (complex A, 
Fig, 2a, lane 2) when used with a HcLa cell nuclear ex- 
tract but no complex formation was observed with glial 
cell nuclear extracts in mobility shift assays (Fig. 2a, 
lane I). In order co check the possibility chat a glial cell 
protein may bc interacting with duplex C with lower af- 
finity resulting in a protein.-DNA complex that is too 
weak co survive elcctrophoresis, we crosslinked any 
bound protein co the duplex by UV-light irradiation. 
The resulting mixture was run on a native polyacryl- 
amide gel. A protein-DNA complex closely matching 
complex A formed with HeLa cell extract was now 
observed with the glial cell extract (Fig. 2b, lane 1), sug- 
gesting that, indeed, proteins present in the glial cell ex- 
tract also bind to this negative regulatory element of 
JCV early promoter, albeit with less affinity when com- 
pared to proteins present in HeLa cells. An additional, 
weaker, slower moving complex was observed with 
HeLa cell extract (complex B). Complex A observed 
with glial or HeLa cell extract was competed away by 
20-fold excess of homologous competitor (Duplex C) 
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but it was unaffected by similar excess of heterologous 
competitor (Duplex D). Complex B appeared to be non- 
specific as it was competed by both, homologous and 
heterologous competitors. When the crosslinked prod- 
ucts were run on SDS-polyacrylamide gel, to determine 
the molecular mass of proteins binding directly to 
duplex C, proteins of about 53 kDa were observed with 
both glial and HeLa cell extracts (Fig. 3). 
Fig, 2. (a) Gel retardation of duplex C in the presence of (1) C6 glioma 
nuclear extract and (2) HeLa cell nuclear extract. (b) Gel retardation 
of duplex C was done in the presence of (I and 4) no competitor, (2 
and 5) 20-fold excess of duplex C. and (3 and 6) 20-fold EXCESS of 
duplex D. After the binding reaction, the proteins bound to DNA 
were crosslinked and electrophoresed on 10% native polyacrylamide 
gels. 
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Fig* 3O Photocrosslinkiny or duplex C to nuclear exrrnet in the prea- 
cnec or (1 and 4) n3 compefiror, (2 and 5) IO&ferld excess of duplex 
D, and (3 nnd 6) lOO&ld cxces~i or unlttbeled duplex C. The wnples 
were cleetrophorcsed on 12% SBS.polyacrylanridc gels, 
duplex containing NFI binding domain (duplex B, 
Fig. 1) has been found to interact with very distinct pro- 
teins in glial and HeLa cells [7,151, WC tried to study the 
interaction of the 53 kDa proteins with the NE1 domain 
to get an insight into the tissue-specific expression of 
JCV. Whereas the binding of the 53 kDa protein ro 
duplex C was not affected by a la)-fold excess of 
duplex D (NFl domain) in HeLa cell extracts, the bind- 
ing of glial protein was affected to some extent by simi- 
lar excess of duplex D (Fig. 3). Both proteins were com- 
peted by a itSfold excess of duplex C. 
The present study suggests that both glial and HeLa 
cells have a 53 kDa protein which binds to the putative 
negative regulatory region of JCV early promoter; The 
glial protein has poor affinity for its binding domain as 
compared to the HeLa protein which binds very tightly 
and may, therefore, contribute to the negative regula- 
tion of JW early promoter in WeLa cells. These pro- 
teins were found to interact differentially to the NFl 
binding domain (present in duplex D), suggesting that 
an interplay of the 53 kDa protein and NFl may con- 
tribute, at least in part, to the tissue-specific expression 
of JCV earfy genes. It is not clear how the interaction of 
fn 6 recent srud~, which apizeared uring the w&km 
OF this manuscript, the AQGCIAAGGGA domain has 
been shown to be responsible for the negative regula- 
tian of the JCV late promoter [16], 
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